Glycomine
San Carlos
About Glycomine
Glycomine is early-stage biotech working on replacement therapies for rare diseases. There are approximately 7,000 rare disorders worldwide. Each day more are being discovered. 95% of rare diseases have not one single FDA-approved treatment. Glycomine develops therapeutics for diseases that have no treatment options.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $195.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Apr 2025)
- Website: glycomine.com
- Phone: (415)617-5755
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/glycomine-104684 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.